The Codex Alimentarius Commission’s Committee on Food Labelling has forwarded updated guidance on precautionary allergen labeling—the “may contain” warnings on food packages—that establishes for the first time a reference dose for cereals containing gluten. The Celiac Disease Foundation announced that the 49th Session of the Codex Committee on Food Labelling (CCFL49) approved the guidance for final adoption, marking what advocates call an important milestone for the celiac community.
This development builds on momentum we covered earlier this year when the FDA signaled its intent to strengthen gluten labeling enforcement domestically. Now the international standard-setting body has moved forward with complementary guidance that could influence how companies approach precautionary labeling worldwide.
What Changed and Why It Matters
The updated Codex guidance strengthens the scientific foundation for when manufacturers should use “may contain” statements for gluten. Critically, the guidance establishes a reference dose for cereals containing gluten while preserving the existing 20 parts per million (ppm) threshold for gluten-free claims.
For families like mine navigating the gluten-free diet, precautionary allergen labeling has always occupied an uncomfortable gray zone. When a package warns “may contain wheat” or “produced in a facility that processes wheat,” what does that actually mean? How much risk are we accepting when we decide to purchase—or avoid—that product?
The answer has traditionally been: nobody knows. Some manufacturers apply these warnings liberally out of legal caution even when cross-contact risk is negligible. Others use them more selectively based on actual production conditions. Without standardized guidance, celiac patients and parents have been left to make individual risk calculations with incomplete information.
The Reference Dose Framework
The concept of a reference dose provides a science-based threshold for when precautionary labeling is warranted. Rather than leaving decisions to each company’s legal department, the guidance establishes an international benchmark rooted in research about what levels of gluten exposure pose genuine risk.
The Celiac Disease Foundation notes this is the first time cereals containing gluten have been included in such guidance at the Codex level. That matters because gluten is not technically an allergen in the classical immunological sense—celiac disease is an autoimmune condition, not an IgE-mediated allergy—which has sometimes left it in a regulatory gray area compared to the major food allergens.
By establishing gluten-specific guidance within the precautionary labeling framework, Codex recognizes what the celiac community has long known: gluten cross-contact deserves the same rigorous attention as peanut or shellfish contamination for people who cannot tolerate it.
What This Does NOT Change
The guidance maintains the established 20 ppm standard for gluten-free labeling. Products labeled “gluten-free” must still meet that threshold. This update addresses a different category: products that are not labeled gluten-free but might contain trace amounts of gluten from cross-contact during manufacturing.
This distinction is crucial. The gluten-free standard remains intact. What changes is the framework manufacturers should use when deciding whether to apply precautionary “may contain” language to products that don’t carry a gluten-free claim.
The International Impact
Codex Alimentarius standards don’t automatically become national law, but they carry significant weight. More than 180 countries participate in Codex, and many use its standards as the foundation for their own food safety regulations. When Codex adopts guidance, it creates momentum for harmonization across borders.
For celiac families who travel internationally or purchase imported products, harmonized standards matter. They reduce the confusion that comes from navigating different labeling regimes in different countries. They also create a shared vocabulary that manufacturers can use regardless of where they’re producing or selling food.
The Celiac Disease Foundation’s participation in this process—represented at CCFL49 alongside Celiac Canada and the Association of European Coeliac Societies—reflects years of advocacy work to ensure that international food standards account for the needs of people who must avoid gluten for medical reasons.
What Happens Next
The guidance now moves to the Codex Alimentarius Commission for final adoption. Once adopted, the work shifts to implementation: how national governments incorporate the guidance into their regulations, and how manufacturers adjust their labeling practices in response.
In the United States, the FDA maintains its own regulatory authority over food labeling. The agency has been moving independently toward strengthened gluten labeling enforcement, as reported in food industry publications earlier this year. The Codex guidance provides additional international support for science-based approaches to precautionary labeling.
Why Science-Based Standards Matter
As someone who reads every ingredient label for my son and evaluates every “may contain” warning, I know how exhausting it is to make these decisions without clear information. The gluten-free diet requires constant vigilance, and precautionary labels add an extra layer of uncertainty to every shopping trip.
Science-based guidance doesn’t eliminate all risk or make every decision easy. But it does shift the conversation from pure legal liability management to evidence-based risk assessment. It gives manufacturers a clearer framework for when precautionary labeling is warranted based on actual contamination risk rather than hypothetical possibility.
For celiac patients and families, that means precautionary labels might become more meaningful. Instead of broad warnings applied inconsistently, we could see labeling that more accurately reflects genuine cross-contact risk. That would allow for better-informed decisions about which products are safe enough for individual tolerance levels.
The Bigger Picture
This development represents one piece of a larger puzzle. Improved labeling standards work alongside better manufacturing practices, increased awareness, and stronger enforcement to create a safer food environment for people who cannot tolerate gluten.
No single regulatory change solves all the challenges of managing celiac disease. My son still needs to navigate school lunches, birthday parties, restaurant meals, and travel with a condition that requires absolute gluten avoidance. Better labeling standards won’t fix everything.
But they do matter. They represent recognition that the celiac community deserves clear, science-based information to make informed decisions about food safety. They acknowledge that gluten cross-contact is a legitimate concern worthy of the same careful attention as other food safety issues.
As this guidance moves toward final adoption and eventual implementation, the celiac community will be watching to see how it translates into practice—whether it delivers on the promise of more consistent, meaningful precautionary labeling that helps families make safer food choices.
Related Coverage
References
Celiac Disease Foundation. (2026, May 14). CCFL49 Forwards Science-Based Guidance for Precautionary Labeling of Cereals Containing Gluten for Final Adoption. https://celiac.org/2026/05/14/ccfl49-pal/